Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 01001538

CERILLIANT™ Lacosamide-13C, D3 Solution, 100 μg/mL in Acetonitrile, Sold by MilliporeSigma™ Supelco™

Certified reference material

Supplier:  MilliporeSigma Supelco L0271ML

Catalog No. 01-001-538


Explore available promotions
Add to Cart

Description

Description

Lacosamide is a new antiepileptic drug approved by the FDA in late 2008 for the treatment of partial-onset seizures and diabetic neuropathic pain. The drug is marketed under the trade name Vimpat™. This internal standard is suitable for lacosamide testing methods by LC/MS or GC/MS for clinical toxicology, forensic analysis, or urine drug testing.
TRUSTED_SUSTAINABILITY
Specifications

Specifications

75-05-8
UN 1648 3 / PGII
254.30
1 mL
13CC12D3H15N2O3
100 μg/mL in acetonitrile
Ampule
2°C (35.6°F) - closed cup
Product Suggestions

Product Suggestions

Videos
Safety and Handling

Safety and Handling

H332-H319

H312

EINECSNumber : 200-835-2

Recommended Storage : -20°C

SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.

CERILLIANT is a registered trademark of Cerilliant Corporation